The University of Pennsylvania Medical Scientist Training Program was established in 1958 and has received NIGMS T32 funding for 42 years. It is currently the only MSTP that supports both medical and veterinary students and has done so for many years. In keeping with recommendations in the 2014 NIH Physician- Scientist Workforce Report, our primary goal continues to be to identify, train and mentor a diverse group of outstanding men and women who will become the leaders of biomedical human and veterinary research, as well as teachers, clinicians and scholars. To meet this goal, we have established flexible training plans that emphasize the integration of clinical and research training in preparation for careers that will use both. Institutional commitment is reflected in Penn' large annual investment in this program, providing resources that help cover tuition and stipend costs, maintain enrichment activities, and support program administration. Trainee appointments to the T32 are typically made for the first 3 years of the program. MSTP T32 dollars are well leveraged, representing only 17% of the annual cost of the MD/PhD program and 14% of the VMD/PhD program. Admission is open to recent college graduates and to current Penn MD, VMD and PhD students. Selection criteria emphasize academic excellence, research experience, independence, letters of recommendation and a plan for a research career. There are currently 189 MD/PhD and 24 VMD/PhD students. While most do graduate work in the biomedical sciences, 21% are in Biomedical Engineering, Physics, Health Care Economics, History & Sociology of Science, Medical Anthropology or Epidemiology. The proposed training faculty reflects this diversity. It includes 148 junior and senior scholars and physician- scientists at Penn plus 3 NIH intramural investigators who are active members of the Immunology Graduate Group at Penn. Policies are in place to maintain and acquire membership in the training faculty. Attrition is low and the average time to degree has decreased. Outcomes data on the 542 MD/PhD and 75 VMD/PhD graduates shows that approximately 80% of those who have completed postgraduate training are employed by academic centers, research institutes, the biotech and pharmaceutical industries or federal agencies. Many have research funding from the NIH and other sources. Our goals for the next 5 years include: 1) preparing all of our trainees to face the complexities of leading and contributing to basic, translational and clinical research in the 21st century, 2) providing greater exposure to career paths outside academia, 3) maintaining and, when appropriate, shortening the average time to degree, 4) increasing the VMD/PhD program to 30 students and keeping the MD/PhD program on track to include 200 students, and 5) building upon our recent success in attracting and training a diverse group of men and women who will be prepared for the discovery and application of new knowledge.

Public Health Relevance

As the pace at which biomedical research advances increases, there is a greater need than ever for physicians and veterinarians who are trained investigators, working at the intersection between medicine and science to develop new understanding of human and animal biology and new approaches to the treatment and management of disease. The goal of the Medical Scientist Training Program at the University of Pennsylvania is to identify, train and mentor a diverse group of outstanding men and women and to help them become teachers, scholars, and leaders of biomedical research (references 1-9).

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Maas, Stefan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Lewis, Emma L; Sierra, Luz-Jeannette; Barila, Guillermo O et al. (2018) Placental immune state shifts with gestational age. Am J Reprod Immunol 79:e12848
Chadwick, Alexandra C; Evitt, Niklaus H; Lv, Wenjian et al. (2018) Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3. Circulation 137:975-977
Becker, Nora V; Gibbins, Karen J; Perrone, Jeanmarie et al. (2018) Geographic variation in postpartum prescription opioid use: Opportunities to improve maternal safety. Drug Alcohol Depend 188:288-294
Kim, Yong Hoon; Marhon, Sajid A; Zhang, Yuxiang et al. (2018) Rev-erb? dynamically modulates chromatin looping to control circadian gene transcription. Science 359:1274-1277
Carey, Jeffrey N; Mettert, Erin L; Roggiani, Manuela et al. (2018) Regulated Stochasticity in a Bacterial Signaling Network Permits Tolerance to a Rapid Environmental Change. Cell 173:196-207.e14
Thalji, Nabil K; Camire, Rodney M (2017) Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding. Curr Opin Hematol 24:453-459
Poleshko, Andrey; Shah, Parisha P; Gupta, Mudit et al. (2017) Genome-Nuclear Lamina Interactions Regulate Cardiac Stem Cell Lineage Restriction. Cell 171:573-587.e14
Freund-Brown, Jacquelyn; Choa, Ruth; Singh, Brenal K et al. (2017) Cutting Edge: Murine NK Cells Degranulate and Retain Cytotoxic Function without Store-Operated Calcium Entry. J Immunol :
Mellis, Ian A; Gupte, Rohit; Raj, Arjun et al. (2017) Visualizing adenosine-to-inosine RNA editing in single mammalian cells. Nat Methods 14:801-804
Brandstadter, Joshua D; Chen, Huiyao; Jiang, Songfu et al. (2017) IL-18-dependent NKG2D ligand upregulation on accessory cells is mediated by the PI3K/GSK-3 pathway. J Leukoc Biol 101:1317-1323

Showing the most recent 10 out of 239 publications